Disorders of Thrombosis and Hemostasis in Cancer

Christina Hart; Minna Voigtlaender

doi:10.1055/a-2447-6537

Hämostaseologie, Table of Contents

Hamostaseologie 2025; 45(02): 122-124
DOI: 10.1055/a-2447-6537

Editorial

Disorders of Thrombosis and Hemostasis in Cancer

Christina Hart

¹Department of Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany

,

Minna Voigtlaender

²Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany

› Author Affiliations

Abstract

Cancer-associated thrombosis (CAT) remains a critical concern in hematology and oncology, contributing significantly to morbidity and mortality. The interplay between malignancy and hemostasis has been extensively studied, yet it continues to present clinical challenges and opportunities for advancement in prevention, treatment, and management. This special issue of Haemostaseologie—Progress in Haemostasis—Disorders of Thrombosis and Hemostasis in Cancer brings together seven review articles that explore diverse aspects of CAT, shedding light on current practices and emerging trends.

Full Text

References

References
1 Hart C, van Es N, Voigtlaender M. Primary Prevention of Cancer-Associated Thrombosis: Current Perspectives. Hamostaseologie 2025; 45: 127-138
2 Voigtlaender M, Rolling C, Hart C. Treatment of Cancer-Associated Thrombosis: An Update. Hamostaseologie 2025; 45: 139-149
3 Balaian E, Marten S, Beyer-Westendorf J, Trautmann-Grill K. Challenging Situations in the Treatment of Cancer-Associated Thrombosis. Hamostaseologie 2025; 45: 150-157
4 Kasteler R, Albisetti M, Bosch A. Update on Cancer-Associated Venous Thromboembolism in Children. Hamostaseologie 2025; 45: 158-165
5 Koschmieder S, Panse J. Thrombosis at Unusual Sites: Focus on Myeloproliferative Neoplasms and Paroxysmal Nocturnal. Hemoglobinuria. Hamostaseologie 2025; 45: 166-174
6 Rolling CC, Lewirt S, Beitzen-Heineke A, Beckmann L, Bokemeyer C, Alsdorf W, Voigtlaender M, Langer F. Checkpoint Inhibitors, CAR T Cells, and the Hemostatic System: What Do We Know So Far?. Hamostaseologie 2025; 45: 175-187
7 Englisch C, Vladic N, Ay C. Bleeding Risk in Patients with Cancer. Hamostaseologie 2025; 45: 188-203